Pinned
In the MGB Registry, obese individuals without prior CVD but with obstructive CAD on #CoronaryCTA had a similar risk of MACE as those in the #SelectTrial placebo group (pts w/ established CVD). 🫀
Grateful for the guidance of my mentor @RonBlankstein and our @BWHCVImaging team!
Now out in @JACCJournals Our @MassGenBrigham CCTA registry study led by 🌟 @camilavblair : Use of #CoronaryCTA to identify high-risk obese individuals without diabetes who may benefit from #GLP1RA Rx. #SelectTrial @BWHCVImaging
sciencedirect.com/science/articl…


































